Brief: SDI Receives US FDA Approval For New Amalgam Replacement Product 'Stela'

SDI

21/11/2022 02:22

Nov 21 (Reuters) - SDI Ltd  SDI.AX :
    * SDI RECEIVES US FDA APPROVAL FOR NEW AMALGAM REPLACEMENT
PRODUCT
    * REGULATORY APPROVAL RECEIVED FROM U.S. FDA FOR SDI'S
AMALGAM
REPLACEMENT PRODUCT 'STELA'
    * FORMAL LAUNCH OF PRODUCT IN US ANTICIPATED IN Q1FY24

Source text for Eikon:  ID:nASX8vBc7t 
Further company coverage:  SDI.AX 
 ((Reuters.Briefs@thomsonreuters.com;))